RBAMEDIUM SIGNALFINANCIAL10-K

RBA substantially increased capital expenditures while reducing debt levels, indicating significant infrastructure investment funded through improved cash management.

The company appears to be in an investment phase, with capital expenditures growing substantially year-over-year, suggesting either expansion or technology upgrades to support their global marketplace platform. The concurrent debt reduction of 11.1% demonstrates strong cash generation and disciplined capital allocation, though rising SG&A expenses and current liabilities warrant monitoring.

Comparing 2026-02-25 vs 2025-02-26View on EDGAR →
FINANCIAL ANALYSIS

RBA's financial profile shows a company actively investing in growth, with capital expenditures substantially higher year-over-year while simultaneously reducing total debt by $300 million. SG&A expenses grew 17% and current liabilities increased 21.5%, likely reflecting operational expansion and higher activity levels. The overall picture suggests a financially healthy company making significant infrastructure investments while maintaining strong balance sheet discipline through debt reduction.

FINANCIAL STATEMENT CHANGES
Capital Expenditure
Cash Flow
+54.7%
$167.4M$259.0M

Capital expenditure jumped 54.7% — major investment cycle underway; assess returns on deployment.

Share Buybacks
Cash Flow
+26.6%
$42.0M$53.2M

Share repurchases increased 26.6% — management returning capital, signals confidence in intrinsic value.

Current Liabilities
Balance Sheet
+21.5%
$1.3B$1.6B

Current liabilities rose 21.5% — increased short-term obligations, watch current ratio.

SG&A Expense
P&L
+17%
$773.9M$905.2M

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

Inventory
Balance Sheet
+15.1%
$121.5M$139.8M

Inventory built 15.1% — monitor whether demand supports this build or if write-downs may follow.

Total Debt
Balance Sheet
-11.1%
$2.6B$2.3B

Debt reduced 11.1% — deleveraging strengthens balance sheet and reduces financial risk.

LANGUAGE CHANGES
NEW — 2026-02-25
PRIOR — 2025-02-26
ADDED
rba-20251231 false 0001046102 2025 FY P1Y P5Y P1Y http://fasb.org/us-gaap/2025#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2025#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2025#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrent Note 25.
The number of common shares outstanding as of February 18, 2026 was 185.9 million.
The availability and performance of our information technology ( IT ) systems and infrastructure is critical to our business and continued growth.
Failure to comply with anti-bribery, anti-corruption, and anti-money laundering laws, including the U.S.
Third-party claims, litigation, regulatory proceedings or government investigations to which we are subject or in which we become involved, regardless of their merit, could have an adverse effect on our business and results of operations.
+7 more — sign up free →
REMOVED
The number of common shares of the registrant outstanding as of January 31, 2025, was 184,748,861 .
The availability and performance of our information technology ("IT") systems and infrastructure is critical to our business and continued growth.
Our substantial international operations expose us to additional risks that could harm our business, including foreign exchange rate fluctuations that could harm our results of operations.
We are regularly subject to general litigation and other claims, which could have an adverse effect on our business and results of operations.
and its subsidiaries (collectively referred to as RB Global , the Company , "our", "us", or we ) (NYSE TSX: RBA) is a leading global marketplace that provides value-added insights, services, transaction solutions for buyers and sellers of commercial assets and vehicles worldwide.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →